VEGFA and neoplasm: The MSNs-LA delivery system induced S cell cycle arrest, enhanced cytotoxicity and tumor targeting of SO and VEGF siRNA, and improved VEGF siRNA transfection efficiency in ASGPR-overexpressing Huh7 cells, as demonstrated by in vitro testing.